GEV vs EMR

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 21, 2026

GEV

52.8
AI Score
VS
GEV Wins

EMR

49.8
AI Score

Investment Advisor Scores

GEV

Oct 21, 2026
53score
Recommendation
HOLD

EMR

Oct 21, 2026
50score
Recommendation
HOLD

AI Analyst Insights

Detailed Metrics Comparison

Metric GEV EMR Winner
Forward P/E 38.7597 21.4592 EMR
PEG Ratio 1.8622 1.7818 EMR
Revenue Growth 21.9% 7.0% GEV
Earnings Growth 32.8% 23.0% GEV
Tradestie Score 52.8/100 49.8/100 GEV
Profit Margin 23.0% 13.8% GEV
Beta 1.00 1.00 Tie
Implied Volatility N/A N/A Tie
AI Recommendation HOLD HOLD Tie

Relative Price Performance (Last 90 Days)

GEV 1M: -2.6% · 3M: -10.2% EMR 1M: +5.8% · 3M: +12.6%

Current Technical Phase

GEV

Markdown
Sell / avoid

Price below a falling SMA50 (slope -1.8%), weak momentum, RSI 44

RSI (14): 43.9 · Price: $925.92

EMR

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (2.9% over 20 days), RSI 61

RSI (14): 60.6 · Price: $163.11

Fundamentals Snapshot

Metric GEV EMR
Market Cap — —
Forward P/E 37.8 22.4
Trailing P/E 26.0 35.1
Revenue (TTM) — —
Revenue Growth 0.2% 0.1%
Gross Margin 0.2% 0.5%
Operating Margin 0.1% 0.3%
EPS 34.18 4.57
Dividend Yield 0.00% 0.01%

Frequently Asked Questions

Based on our detailed analysis, GEV is currently the stronger investment candidate, winning 4 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.